<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39444690</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era.</ArticleTitle><Pagination><StartPage>1470953</StartPage><MedlinePgn>1470953</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1470953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2024.1470953</ELocationID><Abstract><AbstractText>Since December 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide with devastating immediate or long-term effects on people's health. Although the lungs are the primary organ affected by COVID-19, individuals infected with SARS-CoV-2 also develop systemic lesions involving multiple organs throughout the body, such as the cardiovascular system. Emerging evidence reveals that COVID-19 could generate myocardial fibrosis, termed "COVID-19-associated myocardial fibrosis." It can result from the activation of fibroblasts via the renin-angiotensin-aldosterone system (RAAS), transforming growth factor-β1 (TGF-β1), microRNAs, and other pathways, and can also occur in other cellular interactions with SARS-CoV-2, such as immunocytes, endothelial cells. Nonetheless, to gain a more profound insight into the natural progression of COVID-19-related myocardial fibrosis, additional investigations are necessary. This review delves into the underlying mechanisms contributing to COVID-19-associated myocardial fibrosis while also examining the antifibrotic potential of current COVID-19 treatments, thereby offering guidance for future clinical trials of these medications. Ultimately, we propose future research directions for COVID-19-associated myocardial fibrosis in the post-COVID-19 era, such as artificial intelligence (AI) telemedicine. We also recommend that relevant tests be added to the follow-up of COVID-19 patients to detect myocardial fibrosis promptly.</AbstractText><CopyrightInformation>Copyright © 2024 Wang, Li, Yang, Li, Zhang, Shi, Zhou, Tang and Li.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Zhan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Luwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Clinical Medical College of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Shuai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Zhengrui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Pengpeng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Run</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RAAS</Keyword><Keyword MajorTopicYN="N">TGF-β1</Keyword><Keyword MajorTopicYN="N">mechanisms</Keyword><Keyword MajorTopicYN="N">myocardial fibrosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39444690</ArticleId><ArticleId IdType="pmc">PMC11497467</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2024.1470953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbasi F., Adatorwovor R., Davarpanah M. A., Mansoori Y., Hajiani M., Azodi F., et al. . (2022). A randomized Trial of Sitagliptin and spironolactone with combination therapy in hospitalized adults with COVID-19. J. Endocr. Soc. 6:bvac 017. doi: 10.1210/jendso/bvac017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvac017</ArticleId><ArticleId IdType="pmc">PMC8898039</ArticleId><ArticleId IdType="pubmed">35261932</ArticleId></ArticleIdList></Reference><Reference><Citation>Abonnenc M., Nabeebaccus A. A., Mayr U., Barallobre-Barreiro J., Dong X., Cuello F., et al. . (2013). Extracellular matrix secretion by cardiac fibroblasts: role of micro RNA-29b and micro RNA-30c. Circ. Res. 113, 1138–1147. doi: 10.1161/CIRCRESAHA.113.302400</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.113.302400</ArticleId><ArticleId IdType="pubmed">24006456</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Margarucci L. M., Scaramucci E., Orsini M., Salerno G., Di Sante G., et al. . (2020). Serum S100B protein as a marker of severity in Covid-19 patients. Sci. Rep. 10:18665. doi: 10.1038/s41598-020-75618-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75618-0</ArticleId><ArticleId IdType="pmc">PMC7596559</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal R., Kolkhof P., Bakris G., Bauersachs J., Haller H., Wada T., et al. . (2021). Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine. Eur. Heart J. 42, 152–161. doi: 10.1093/eurheartj/ehaa736</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa736</ArticleId><ArticleId IdType="pmc">PMC7813624</ArticleId><ArticleId IdType="pubmed">33099609</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiestaran-Zelaia I., Sanchez-Guisado M. J., Villar-Fernandez M., Azkargorta M., Fadon-Padilla L., Fernandez-Pelayo U., et al. . (2022). 2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart. Sci. Rep. 12:6890. doi: 10.1038/s41598-022-10168-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10168-1</ArticleId><ArticleId IdType="pmc">PMC9044724</ArticleId><ArticleId IdType="pubmed">35478201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmera V., Thompson W. K., Smith D. M., Malhotra A., Mehta R. L., Tolia V., et al. . (2021). RAMIC: design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp. Clin. Trials 103:106330. doi: 10.1016/j.cct.2021.106330, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2021.106330</ArticleId><ArticleId IdType="pmc">PMC7899027</ArticleId><ArticleId IdType="pubmed">33631357</ArticleId></ArticleIdList></Reference><Reference><Citation>Akazawa H., Yano M., Yabumoto C., Kudo-Sakamoto Y., Komuro I. (2013). Angiotensin II type 1 and type 2 receptor-induced cell signaling. Curr. Pharm. Des. 19, 2988–2995. doi: 10.2174/1381612811319170003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612811319170003</ArticleId><ArticleId IdType="pubmed">23176210</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J. L., Mullish B. H., Danckert N. P., Liu Z., Olbei M. L., Saifuddin A., et al. . (2023). The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients. EBioMedicine 88:104430. doi: 10.1016/j.ebiom.2022.104430, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104430</ArticleId><ArticleId IdType="pmc">PMC9831064</ArticleId><ArticleId IdType="pubmed">36634565</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzayadneh E. M., Chappell M. C. (2014). Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2. Cell. Signal. 26, 3027–3035. doi: 10.1016/j.cellsig.2014.09.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2014.09.010</ArticleId><ArticleId IdType="pmc">PMC4254268</ArticleId><ArticleId IdType="pubmed">25246357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames M. K., Atkins C. E., Pitt B. (2019). The renin-angiotensin-aldosterone system and its suppression. J. Vet. Intern. Med. 33, 363–382. doi: 10.1111/jvim.15454, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.15454</ArticleId><ArticleId IdType="pmc">PMC6430926</ArticleId><ArticleId IdType="pubmed">30806496</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirian E. S., Levy J. K. (2020). Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health 9:100128. doi: 10.1016/j.onehlt.2020.100128, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.onehlt.2020.100128</ArticleId><ArticleId IdType="pmc">PMC7118644</ArticleId><ArticleId IdType="pubmed">32258351</ArticleId></ArticleIdList></Reference><Reference><Citation>Amri N., Begin R., Tessier N., Vachon L., Villeneuve L., Begin P., et al. . (2022). Use of early donated COVID-19 convalescent plasma is optimal to preserve the integrity of lymphatic endothelial cells. Pharmaceuticals (Basel) 15:365. doi: 10.3390/ph15030365, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15030365</ArticleId><ArticleId IdType="pmc">PMC8948637</ArticleId><ArticleId IdType="pubmed">35337162</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelberg S., Gupta S., Svensson Akusjarvi S., Ambikan A. T., Mikaeloff F., Saccon E., et al. . (2020). Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg. Microbes Infect. 9, 1748–1760. doi: 10.1080/22221751.2020.1799723, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1799723</ArticleId><ArticleId IdType="pmc">PMC7473213</ArticleId><ArticleId IdType="pubmed">32691695</ArticleId></ArticleIdList></Reference><Reference><Citation>Arhancet G. B., Woodard S. S., Iyanar K., Case B. L., Woerndle R., Dietz J. D., et al. . (2010). Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonists. J. Med. Chem. 53, 5970–5978. doi: 10.1021/jm100506y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm100506y</ArticleId><ArticleId IdType="pubmed">20672820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey A. L., Dmytrenko O., Greenberg L., Bredemeyer A. L., Ma P., Liu J., et al. . (2021). SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl. Sci. 6, 331–345. doi: 10.1016/j.jacbts.2021.01.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshi H., Michelhaugh S. A., Bruce S. A., Seliger S. L., Qian X., Ambale Venkatesh B., et al. . (2023). Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis. EBioMedicine 90:104490. doi: 10.1016/j.ebiom.2023.104490, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104490</ArticleId><ArticleId IdType="pmc">PMC10006438</ArticleId><ArticleId IdType="pubmed">36857966</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal S. S., Ismahil M. A., Goel M., Patel B., Hamid T., Rokosh G., et al. . (2017). Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. Circ. Heart Fail. 10:e003688. doi: 10.1161/CIRCHEARTFAILURE.116.003688, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.003688</ArticleId><ArticleId IdType="pmc">PMC5331621</ArticleId><ArticleId IdType="pubmed">28242779</ArticleId></ArticleIdList></Reference><Reference><Citation>Barut F., Ozacmak V. H., Turan I., Sayan-Ozacmak H., Aktunc E. (2016). Reduction of acute lung injury by Administration of Spironolactone after Intestinal Ischemia and Reperfusion in rats. Clin. Invest. Med. 39, E15–E24. doi: 10.25011/cim.v39i1.26326</Citation><ArticleIdList><ArticleId IdType="doi">10.25011/cim.v39i1.26326</ArticleId><ArticleId IdType="pubmed">26833169</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Leone O., Rizzo S., De Gaspari M., van der Wal A. C., Aubry M. C., et al. . (2020). Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 41, 3827–3835. doi: 10.1093/eurheartj/ehaa664, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauersachs J., Jaisser F., Toto R. (2015). Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension 65, 257–263. doi: 10.1161/HYPERTENSIONAHA.114.04488</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.04488</ArticleId><ArticleId IdType="pubmed">25368026</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigel J. H., Tomashek K. M., Dodd L. E., Mehta A. K., Zingman B. S., Kalil A. C., et al. . (2020). Remdesivir for the treatment of Covid-19- final report. N. Engl. J. Med. 383, 1813–1826. doi: 10.1056/NEJMoa2007764, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007764</ArticleId><ArticleId IdType="pmc">PMC7262788</ArticleId><ArticleId IdType="pubmed">32445440</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellicini M. G., D'Altilia F. P., Gussago C., Adamo M., Lombardi C. M., Tomasoni D., et al. . (2023). Telemedicine for the treatment of heart failure: new opportunities after COVID-19. J. Cardiovasc. Med. (Hagerstown) 24, 700–707. doi: 10.2459/JCM.0000000000001514, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001514</ArticleId><ArticleId IdType="pubmed">37409660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharat A., Querrey M., Markov N. S., Kim S., Kurihara C., Garza-Castillon R., et al. . (2020). Lung transplantation for patients with severe COVID-19. Sci. Transl. Med. 12:4282. doi: 10.1126/scitranslmed.abe4282, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe4282</ArticleId><ArticleId IdType="pmc">PMC8050952</ArticleId><ArticleId IdType="pubmed">33257409</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt A. N., Kumar A., Rai Y., Kumari N., Vedagiri D., Harshan K. H., et al. . (2022a). Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions. Life Sci. 295:120411. doi: 10.1016/j.lfs.2022.120411, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.120411</ArticleId><ArticleId IdType="pmc">PMC8847085</ArticleId><ArticleId IdType="pubmed">35181310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt A. N., Shenoy S., Munjal S., Chinnadurai V., Agarwal A., Vinoth Kumar A., et al. . (2022b). 2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial. BMC Infect. Dis. 22:669. doi: 10.1186/s12879-022-07642-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07642-6</ArticleId><ArticleId IdType="pmc">PMC9351257</ArticleId><ArticleId IdType="pubmed">35927676</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnhuber A., Fliesser E., Gorkiewicz G., Zacharias M., Seeliger B., David S., et al. . (2021). Between inflammation and thrombosis: endothelial cells in COVID-19. Eur. Respir. J. 58:2100377. doi: 10.1183/13993003.00377-2021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00377-2021</ArticleId><ArticleId IdType="pmc">PMC8112008</ArticleId><ArticleId IdType="pubmed">33958433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Klann K., Koch B., Widera M., Krause D., Ciesek S., et al. . (2020a). Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469–472. doi: 10.1038/s41586-020-2332-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2332-7</ArticleId><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., Wagner J. U. G., Shumliakivska M., Aslan G. S., Saleem U., Hansen A., et al. . (2020b). SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc. Res. 116, 2207–2215. doi: 10.1093/cvr/cvaa267, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa267</ArticleId><ArticleId IdType="pmc">PMC7543363</ArticleId><ArticleId IdType="pubmed">32966582</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon R. A., Seeger T., Heydt S., Fischer A., Hergenreider E., Horrevoets A. J., et al. . (2011). Micro RNA-29 in aortic dilation: implications for aneurysm formation. Circ. Res. 109, 1115–1119. doi: 10.1161/CIRCRESAHA.111.255737, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.255737</ArticleId><ArticleId IdType="pubmed">21903938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzi G., Mangioni D., Minoia F., Aliberti S., Grasselli G., Barbetta L., et al. . (2021). Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study. J. Allergy Clin. Immunol. 147, 561–566.e4. doi: 10.1016/j.jaci.2020.11.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7674131</ArticleId><ArticleId IdType="pubmed">33220354</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenhielm E., Alitalo K. (2019). Cardiac lymphatics in health and disease. Nat. Rev. Cardiol. 16, 56–68. doi: 10.1038/s41569-018-0087-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0087-8</ArticleId><ArticleId IdType="pubmed">30333526</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenhielm E., Gonzalez A., Diez J. (2020). Role of cardiac lymphatics in myocardial edema and fibrosis: JACC review topic of the week. J. Am. Coll. Cardiol. 76, 735–744. doi: 10.1016/j.jacc.2020.05.076, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.05.076</ArticleId><ArticleId IdType="pubmed">32762908</ArticleId></ArticleIdList></Reference><Reference><Citation>Brilla C. G. (2000). Aldosterone and myocardial fibrosis in heart failure. Herz 25, 299–306. doi: 10.1007/s000590050024</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000590050024</ArticleId><ArticleId IdType="pubmed">10904856</ArticleId></ArticleIdList></Reference><Reference><Citation>Brilla C. G., Funck R. C., Rupp H. (2000). Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102, 1388–1393. doi: 10.1161/01.CIR.102.12.1388, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.102.12.1388</ArticleId><ArticleId IdType="pubmed">10993857</ArticleId></ArticleIdList></Reference><Reference><Citation>Budi E. H., Duan D., Derynck R. (2017). Transforming growth factor-beta receptors and Smads: regulatory complexity and functional versatility. Trends Cell Biol. 27, 658–672. doi: 10.1016/j.tcb.2017.04.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2017.04.005</ArticleId><ArticleId IdType="pubmed">28552280</ArticleId></ArticleIdList></Reference><Reference><Citation>Buja L. M., Wolf D. A., Zhao B., Akkanti B., McDonald M., Lelenwa L., et al. . (2020). The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc. Pathol. 48:107233. doi: 10.1016/j.carpath.2020.107233, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107233</ArticleId><ArticleId IdType="pmc">PMC7204762</ArticleId><ArticleId IdType="pubmed">32434133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S. M., Yang R. Q., Li Y., Ning Z. W., Zhang L. L., Zhou G. S., et al. . (2016). Angiotensin-(1-7) improves liver fibrosis by regulating the NLRP3 Inflammasome via redox balance modulation. Antioxid. Redox Signal. 24, 795–812. doi: 10.1089/ars.2015.6498, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6498</ArticleId><ArticleId IdType="pubmed">26728324</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W., Zhong S., Zheng F., Zhang Y., Gao F., Xu H., et al. . (2019). Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1/ERK1/2/RSK1 pathway. IUBMB Life 71, 261–276. doi: 10.1002/iub.1967</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1967</ArticleId><ArticleId IdType="pubmed">30452117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q., Du X., Jiang X. Y., Tian Y., Gao C. H., Liu Z. Y., et al. . (2023). Phenome-wide association study and precision medicine of cardiovascular diseases in the post-COVID-19 era. Acta Pharmacol. Sin. 44, 2347–2357. doi: 10.1038/s41401-023-01119-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-023-01119-1</ArticleId><ArticleId IdType="pmc">PMC10692238</ArticleId><ArticleId IdType="pubmed">37532784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Nguyen V., Tsai J., Gao C., Tian Y., Zhang Y., et al. . (2023). The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice. Mol. Metab. 74:101756. doi: 10.1016/j.molmet.2023.101756, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2023.101756</ArticleId><ArticleId IdType="pmc">PMC10281040</ArticleId><ArticleId IdType="pubmed">37348737</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao T. T., Zhang G. Q., Pellegrini E., Zhao Q., Li J., Luo L. J., et al. . (2021). COVID-19 and its effects on the digestive system. World J. Gastroenterol. 27, 3502–3515. doi: 10.3748/wjg.v27.i24.3502, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v27.i24.3502</ArticleId><ArticleId IdType="pmc">PMC8240057</ArticleId><ArticleId IdType="pubmed">34239265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cayrol C., Girard J. P. (2018). Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol. Rev. 281, 154–168. doi: 10.1111/imr.12619</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12619</ArticleId><ArticleId IdType="pubmed">29247993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K. R., Koh C. W. T., Ng D. H. L., Qin S., Ooi J. S. G., Ong E. Z., et al. . (2023). Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis. EBioMedicine 89:104472. doi: 10.1016/j.ebiom.2023.104472, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104472</ArticleId><ArticleId IdType="pmc">PMC9934388</ArticleId><ArticleId IdType="pubmed">36801619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W. T., Cheng J. T., Chen Z. C. (2016). Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor delta (PPARdelta): from bedside to bench. Cardiovasc. Diabetol. 15:113. doi: 10.1186/s12933-016-0430-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0430-5</ArticleId><ArticleId IdType="pmc">PMC4983091</ArticleId><ArticleId IdType="pubmed">27519769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z. T., Gao Q. Y., Wu M. X., Wang M., Sun R. L., Jiang Y., et al. . (2021). Glycolysis inhibition alleviates cardiac fibrosis after myocardial infarction by suppressing cardiac fibroblast activation. Front. Cardiovasc. Med. 8:701745. doi: 10.3389/fcvm.2021.701745, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.701745</ArticleId><ArticleId IdType="pmc">PMC8511672</ArticleId><ArticleId IdType="pubmed">34660710</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li X., Chen M., Feng Y., Xiong C. (2020). The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 116, 1097–1100. doi: 10.1093/cvr/cvaa078, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Shi J., Zhang Y., Miao J., Zhao Z., Jin X., et al. . (2020). An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction. J. Mater. Chem. B 8, 980–992. doi: 10.1039/C9TB02523E, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9TB02523E</ArticleId><ArticleId IdType="pubmed">31930242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang W., Chen F., Cui L. (2022). COVID-19 and cognitive impairment: neuroinvasive and blood–brain barrier dysfunction. J. Neuroinflammation 19:222. doi: 10.1186/s12974-022-02579-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02579-8</ArticleId><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Yang L., Nilsson-Payant B., Han Y., Jaffré F., Zhu J., et al. . (2020). SARS-CoV-2 infected cardiomyocytes recruit monocytes by secreting CCL2. Res. Sq. 17:94634. doi: 10.21203/rs.3.rs-94634/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-94634/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh F. W., Fong S. W., Young B. E., Wu K. X., Siau A., Krishnan S., et al. . (2021). Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife 10:e64909. doi: 10.7554/eLife.64909</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C. H., Hung C. S., Liao C. W., Wei L. H., Chen C. W., Shun C. T., et al. . (2018). IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis. Cardiovasc. Res. 114, 690–702. doi: 10.1093/cvr/cvy013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy013</ArticleId><ArticleId IdType="pubmed">29360942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M. K., Zidar D. A., Bristow M. R., Cameron S. J., Chan T., Harding C. V., et al. . (2021). COVID-19 and cardiovascular disease: from bench to bedside. Circ. Res. 128, 1214–1236. doi: 10.1161/CIRCRESAHA.121.317997, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciulla M. M., Paliotti R., Esposito A., Cuspidi C., Muiesan M. L., Rosei E. A., et al. . (2009). Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril. J. Hypertens. 27, 626–632. doi: 10.1097/HJH.0b013e3283232838, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0b013e3283232838</ArticleId><ArticleId IdType="pubmed">19262230</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo A. C., Davanzo G. G., Monteiro L. B., de Souza G. F., Muraro S. P., Virgilio-da-Silva J. V., et al. . (2020). Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha/glycolysis-dependent Axis. Cell Metab. 32, 437–446.e5. doi: 10.1016/j.cmet.2020.07.007, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. B., Bancos I., Brown J. M., Sarathy H., Turcu A. F., Cohen D. L. (2023). Primary Aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys. Annu. Rev. Med. 74, 217–230. doi: 10.1146/annurev-med-042921-100438, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-042921-100438</ArticleId><ArticleId IdType="pmc">PMC9892285</ArticleId><ArticleId IdType="pubmed">36375469</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C., Maglio A., Terlizzi M., Vitale C., Molino A., Pinto A., et al. . (2021). Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of IFN-beta but higher levels of IL-1alpha and TGF-beta. Biomedicines 9:1931. doi: 10.3390/biomedicines9121931</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121931</ArticleId><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E. A., Haghbayan H. (2020). Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev. Med. Virol. 30, 1–9. doi: 10.1002/rmv.2141, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Corovic A., Zhao X., Huang Y., Newland S., Gopalan D., Harrison J., et al. . (2024). COVID-19 related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac MRI abnormalities. Cardiovasc. Res. 1:cvae159. doi: 10.1093/cvr/cvae159</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvae159</ArticleId><ArticleId IdType="pubmed">39073768</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten M. F., Dennert R., Jochems S., Kuznetsova T., Devaux Y., Hofstra L., et al. . (2010). Circulating Micro RNA-208b and Micro RNA-499 reflect myocardial damage in cardiovascular disease. Circ. Cardiovasc. Genet. 3, 499–506. doi: 10.1161/CIRCGENETICS.110.957415, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.110.957415</ArticleId><ArticleId IdType="pubmed">20921333</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabos M., Roth M., Hahn A. W., Erne P. (1994). Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J. Clin. Invest. 93, 2372–2378. doi: 10.1172/JCI117243, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI117243</ArticleId><ArticleId IdType="pmc">PMC294443</ArticleId><ArticleId IdType="pubmed">8200970</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta P. K., Liu F., Fischer T., Rappaport J., Qin X. (2020). SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics 10, 7448–7464. doi: 10.7150/thno.48076, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.48076</ArticleId><ArticleId IdType="pmc">PMC7330865</ArticleId><ArticleId IdType="pubmed">32642005</ArticleId></ArticleIdList></Reference><Reference><Citation>Deftereos S. G., Giannopoulos G., Vrachatis D. A., Siasos G. D., Giotaki S. G., Gargalianos P., et al. . (2020). Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical Trial. JAMA Netw. Open 3:e2013136. doi: 10.1001/jamanetworkopen.2020.13136</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.13136</ArticleId><ArticleId IdType="pmc">PMC7315286</ArticleId><ArticleId IdType="pubmed">32579195</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle D. M., Kim-Schulze S., Huang H. H., Beckmann N. D., Nirenberg S., Wang B., et al. . (2020). An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636–1643. doi: 10.1038/s41591-020-1051-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey T. M., Ziegler C. G. K., Heimberg G., Normand R., Yang Y., Segerstolpe A., et al. . (2021). COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107–113. doi: 10.1038/s41586-021-03570-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Divakaran V., Adrogue J., Ishiyama M., Entman M. L., Haudek S., Sivasubramanian N., et al. . (2009). Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ. Heart Fail. 2, 633–642. doi: 10.1161/CIRCHEARTFAILURE.108.823070, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.108.823070</ArticleId><ArticleId IdType="pmc">PMC3064555</ArticleId><ArticleId IdType="pubmed">19919989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S., Ma W., Hao B., Hu F., Yan L., Yan X., et al. . (2014). micro RNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int. J. Clin. Exp. Pathol. 7, 565–574, PMID:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3925900</ArticleId><ArticleId IdType="pubmed">24551276</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi T., Bokharaei-Salim F., Baghi H. B., Khanaliha K., Alaei Janat-Makan M., Karimi B., et al. . (2021). Acute and post-acute phase of COVID-19: analyzing expression patterns of mi RNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int. Immunopharmacol. 97:107641. doi: 10.1016/j.intimp.2021.107641, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte M., Pelorosso F., Nicolosi L. N., Salgado M. V., Vetulli H., Aquieri A., et al. . (2021). Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial. EClinicalMedicine. 37:100962. doi: 10.1016/j.eclinm.2021.100962, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100962</ArticleId><ArticleId IdType="pmc">PMC8225700</ArticleId><ArticleId IdType="pubmed">34189447</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkahloun A. G., Saavedra J. M. (2020). Candesartan could ameliorate the COVID-19 cytokine storm. Biomed. Pharmacother. 131:110653. doi: 10.1016/j.biopha.2020.110653, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110653</ArticleId><ArticleId IdType="pmc">PMC7439834</ArticleId><ArticleId IdType="pubmed">32942152</ArticleId></ArticleIdList></Reference><Reference><Citation>Espin E., Yang C., Shannon C. P., Assadian S., He D., Tebbutt S. J. (2023). Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine 91:104552. doi: 10.1016/j.ebiom.2023.104552, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M., Fejes Z., Suto R., Nagy Z., Szekely B., Pocsi M., et al. . (2022). Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int. J. Infect. Dis. 115, 8–16. doi: 10.1016/j.ijid.2021.11.028, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.028</ArticleId><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Farbehi N., Patrick R., Dorison A., Xaymardan M., Janbandhu V., Wystub-Lis K., et al. . (2019). Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. eLife 8:8. doi: 10.7554/eLife.43882</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.43882</ArticleId><ArticleId IdType="pmc">PMC6459677</ArticleId><ArticleId IdType="pubmed">30912746</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria-Costa G., Leite-Moreira A., Henriques-Coelho T. (2014). Cardiovascular effects of the angiotensin type 2 receptor. Rev. Port. Cardiol. 33, 439–449. doi: 10.1016/j.repc.2014.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2014.02.011</ArticleId><ArticleId IdType="pubmed">25087493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario C. M., Jessup J., Chappell M. C., Averill D. B., Brosnihan K. B., Tallant E. A., et al. . (2005). Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111, 2605–2610. doi: 10.1161/CIRCULATIONAHA.104.510461</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Munoz M., Work L. M., Douglas K., Denby L., Dominiczak A. F., Graham D., et al. . (2012). Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension 59, 300–307. doi: 10.1161/HYPERTENSIONAHA.111.177485, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.177485</ArticleId><ArticleId IdType="pubmed">22184331</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N. G. (2019). Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol. Asp. Med. 65, 70–99. doi: 10.1016/j.mam.2018.07.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2018.07.001</ArticleId><ArticleId IdType="pubmed">30056242</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N. G. (2024). The fate and role of the pericytes in myocardial diseases. Eur. J. Clin. Investig. 54:e14204. doi: 10.1111/eci.14204, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.14204</ArticleId><ArticleId IdType="pubmed">38586936</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzén P., ten Dijke P., Ichijo H., Yamashita H., Schulz P., Heldin C. H., et al. . (1993). Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75, 681–692. doi: 10.1016/0092-8674(93)90489-D</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90489-D</ArticleId><ArticleId IdType="pubmed">8242743</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Seeliger B., Derda A. A., Xiao K., Gietz A., Scherf K., et al. . (2021). Circulating cardiovascular micro RNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 23, 468–475. doi: 10.1002/ejhf.2096, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin A. M., Khokhar B. S., Czubryt M. P., Hale T. M. (2021). RAS inhibition in resident fibroblast biology. Cell. Signal. 80:109903. doi: 10.1016/j.cellsig.2020.109903, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2020.109903</ArticleId><ArticleId IdType="pmc">PMC7878352</ArticleId><ArticleId IdType="pubmed">33370581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Z., Chen Y., Wang B., Zhang X., Yan Y., Zhou L., et al. . (2020). MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-beta 1/Smad 2/3 pathway. J. Mol. Cell. Cardiol. 139, 164–175. doi: 10.1016/j.yjmcc.2020.01.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.01.001</ArticleId><ArticleId IdType="pubmed">31958465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazavi A., Ganji A., Keshavarzian N., Rabiemajd S., Mosayebi G. (2021). Cytokine profile and disease severity in patients with COVID-19. Cytokine 137:155323. doi: 10.1016/j.cyto.2020.155323, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155323</ArticleId><ArticleId IdType="pmc">PMC7524708</ArticleId><ArticleId IdType="pubmed">33045526</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J. C., Turner A. J., et al. . (2020). Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 126, 1456–1474. doi: 10.1161/CIRCRESAHA.120.317015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibb A. A., Lazaropoulos M. P., Elrod J. W. (2020). Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ. Res. 127, 427–447. doi: 10.1161/CIRCRESAHA.120.316958, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.316958</ArticleId><ArticleId IdType="pmc">PMC7982967</ArticleId><ArticleId IdType="pubmed">32673537</ArticleId></ArticleIdList></Reference><Reference><Citation>Giugni F. R., Aiello V. D., Faria C. S., Pour S. Z., Cunha M. D. P., Giugni M. V., et al. . (2023). Understanding yellow fever-associated myocardial injury: an autopsy study. EBioMedicine 96:104810. doi: 10.1016/j.ebiom.2023.104810, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104810</ArticleId><ArticleId IdType="pmc">PMC10550587</ArticleId><ArticleId IdType="pubmed">37757571</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G., Croft L. B., Stefanini G. G., Bragato R., Silbiger J. J., Vicenzi M., et al. . (2020). Characterization of myocardial injury in patients with COVID-19. J. Am. Coll. Cardiol. 76, 2043–2055. doi: 10.1016/j.jacc.2020.08.069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.069</ArticleId><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong H., Lyu X., Wang Q., Hu M., Zhang X. (2017). Endothelial to mesenchymal transition in the cardiovascular system. Life Sci. 184, 95–102. doi: 10.1016/j.lfs.2017.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.07.014</ArticleId><ArticleId IdType="pubmed">28716564</ArticleId></ArticleIdList></Reference><Reference><Citation>Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W. (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141–1148. doi: 10.1161/01.RES.74.6.1141</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.74.6.1141</ArticleId><ArticleId IdType="pubmed">8187280</ArticleId></ArticleIdList></Reference><Reference><Citation>Grune J., Beyhoff N., Smeir E., Chudek R., Blumrich A., Ban Z., et al. . (2018). Selective mineralocorticoid receptor cofactor modulation as molecular basis for Finerenone's Antifibrotic activity. Hypertension 71, 599–608. doi: 10.1161/HYPERTENSIONAHA.117.10360</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10360</ArticleId><ArticleId IdType="pubmed">29437893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Han Z. H., Wang C. Q., Zhang J. F. (2024). The impacts of Nirmatrelvir-ritonavir on myocardial injury and long-term cardiovascular outcomes in hospitalized patients with COVID-19 amid the omicron wave of the pandemic. Cardiovasc. Drugs Ther. 11:7570. doi: 10.1007/s10557-024-07570-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-024-07570-4</ArticleId><ArticleId IdType="pubmed">38466547</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri J. W., Dybas J. M., Fazelinia H., Kim M. S., Frere J., Zhang Y., et al. . (2023). Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 15:eabq 1533. doi: 10.1126/scitranslmed.abq1533</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq1533</ArticleId><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference><Reference><Citation>Guido C., Whitaker-Menezes D., Lin Z., Pestell R. G., Howell A., Zimmers T. A., et al. . (2012). Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth. Oncotarget 3, 798–810. doi: 10.18632/oncotarget.574, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.574</ArticleId><ArticleId IdType="pmc">PMC3478457</ArticleId><ArticleId IdType="pubmed">22878233</ArticleId></ArticleIdList></Reference><Reference><Citation>Habimana R., Choi I., Cho H. J., Kim D., Lee K., Jeong I. (2020). Sepsis-induced cardiac dysfunction: a review of pathophysiology. Acute Crit. Care 35, 57–66. doi: 10.4266/acc.2020.00248, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4266/acc.2020.00248</ArticleId><ArticleId IdType="pmc">PMC7280799</ArticleId><ArticleId IdType="pubmed">32506871</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada Y., Kiso Y. (2016). New directions for protease inhibitors directed drug discovery. Biopolymers 106, 563–579. doi: 10.1002/bip.22780, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.22780</ArticleId><ArticleId IdType="pmc">PMC7161749</ArticleId><ArticleId IdType="pubmed">26584340</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann C., Miggiolaro A., Motta J. D. S., Baena Carstens L., De Paula B. V. C., Fagundes Grobe S., et al. . (2021). The pathogenesis of COVID-19 myocardial injury: An immunohistochemical study of postmortem biopsies. Front. Immunol. 12:748417. doi: 10.3389/fimmu.2021.748417, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748417</ArticleId><ArticleId IdType="pmc">PMC8602833</ArticleId><ArticleId IdType="pubmed">34804033</ArticleId></ArticleIdList></Reference><Reference><Citation>Haudek S. B., Cheng J., Du J., Wang Y., Hermosillo-Rodriguez J., Trial J., et al. . (2010). Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 49, 499–507. doi: 10.1016/j.yjmcc.2010.05.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2010.05.005</ArticleId><ArticleId IdType="pmc">PMC2917526</ArticleId><ArticleId IdType="pubmed">20488188</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Xu Y., Koya D., Kanasaki K. (2013). Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin. Exp. Nephrol. 17, 488–497. doi: 10.1007/s10157-013-0781-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10157-013-0781-0</ArticleId><ArticleId IdType="pubmed">23430391</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., et al. . (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280.e8. doi: 10.1016/j.cell.2020.02.052, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Holton S. E., Mitchem M., Pipavath S., Morrell E. D., Bhatraju P. K., Hamerman J. A., et al. . (2023). Mediators of monocyte chemotaxis and matrix remodeling are associated with the development of fibrosis in patients with COVID-19. medRxiv 2023:23289261. doi: 10.1101/2023.04.28.23289261</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.28.23289261</ArticleId><ArticleId IdType="pmc">PMC11302896</ArticleId><ArticleId IdType="pubmed">39106254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong L., Lai H. L., Fang Y., Tao Y., Qiu Y. (2018). Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy. J. Cell. Biochem. 119, 9519–9531. doi: 10.1002/jcb.27268</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.27268</ArticleId><ArticleId IdType="pubmed">30129221</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossen M. S., Barek M. A., Jahan N., Safiqul I. M. (2020). A review on current repurposing drugs for the treatment of COVID-19: reality and challenges. SN Compr. Clin. Med. 2, 1777–1789. doi: 10.1007/s42399-020-00485-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00485-9</ArticleId><ArticleId IdType="pmc">PMC7457893</ArticleId><ArticleId IdType="pubmed">32904710</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D. Q., Ajmera V., Tomaszewski C., LaFree A., Bettencourt R., Thompson W. K., et al. . (2023). Ramipril for the treatment of COVID-19: RAMIC, a randomized, double-blind, placebo-controlled clinical trial. Adv. Ther. 40, 4805–4816. doi: 10.1007/s12325-023-02618-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-023-02618-7</ArticleId><ArticleId IdType="pmc">PMC10709987</ArticleId><ArticleId IdType="pubmed">37615850</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Fan W., Sun J., Yang J., Zhang Y., Wang Q., et al. . (2023). SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor captopril. Antivir. Res. 215:105636. doi: 10.1016/j.antiviral.2023.105636, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2023.105636</ArticleId><ArticleId IdType="pmc">PMC10191704</ArticleId><ArticleId IdType="pubmed">37207821</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. . (2023). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 401, e21–e33. doi: 10.1016/S0140-6736(23)00810-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L. L., Nikolic-Paterson D. J., Ma F. Y., Tesch G. H. (2012). Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K/MAPK signalling. Nephron Exp. Nephrol. 120, e115–e122. doi: 10.1159/000339500, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000339500</ArticleId><ArticleId IdType="pubmed">22814207</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tu M., Wang S., Chen S., Zhou W., Chen D., et al. . (2020). Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med. Infect. Dis. 36:101606. doi: 10.1016/j.tmaid.2020.101606</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101606</ArticleId><ArticleId IdType="pmc">PMC7102650</ArticleId><ArticleId IdType="pubmed">32114074</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. . (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506. doi: 10.1016/S0140-6736(20)30183-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., et al. . (2020). Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc. Imaging 13, 2330–2339. doi: 10.1016/j.jcmg.2020.05.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Humeres C., Frangogiannis N. G. (2019). Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic Transl. Sci. 4, 449–467. doi: 10.1016/j.jacbts.2019.02.006, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC6610002</ArticleId><ArticleId IdType="pubmed">31312768</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C. S., Chou C. H., Liao C. W., Lin Y. T., Wu X. M., Chang Y. Y., et al. . (2016). Aldosterone induces tissue inhibitor of Metalloproteinases-1 expression and further contributes to collagen accumulation: from clinical to bench studies. Hypertension 67, 1309–1320. doi: 10.1161/HYPERTENSIONAHA.115.06768, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.06768</ArticleId><ArticleId IdType="pubmed">27113051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizaki Y., Ooka S., Doi S., Kawasaki T., Sakurai K., Mizushima M., et al. . (2021). Treatment of myocardial fibrosis in systemic sclerosis with tocilizumab. Rheumatology (Oxford) 60:e205-e6. doi: 10.1093/rheumatology/keaa865, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa865</ArticleId><ArticleId IdType="pubmed">33331892</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M. N., Gusarova G. A., Das S. R., Li L., Monma E., Anjaneyulu M., et al. . (2021). The mitochondrial calcium uniporter of pulmonary type 2 cells determines severity of ARDS. bioRxiv 18:427173. doi: 10.1101/2021.01.18.427173</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.18.427173</ArticleId><ArticleId IdType="pmc">PMC9529882</ArticleId><ArticleId IdType="pubmed">36192486</ArticleId></ArticleIdList></Reference><Reference><Citation>Izawa H., Murohara T., Nagata K., Isobe S., Asano H., Amano T., et al. . (2005). Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112, 2940–2945. doi: 10.1161/CIRCULATIONAHA.105.571653</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.571653</ArticleId><ArticleId IdType="pubmed">16275882</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagia P., Ojha V., Naik N., Sharma S. (2020). Myocardial fibrosis detected by cardiovascular magnetic resonance in absence of myocardial oedema in a patient recovered from COVID-19. BMJ Case Rep. 13:193. doi: 10.1136/bcr-2020-240193</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-240193</ArticleId><ArticleId IdType="pmc">PMC10577794</ArticleId><ArticleId IdType="pubmed">33334776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M., Rivera S., Monclus E. A., Synenki L., Zirk A., Eisenbart J., et al. . (2013). Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling. J. Biol. Chem. 288, 770–777. doi: 10.1074/jbc.M112.431973, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431973</ArticleId><ArticleId IdType="pmc">PMC3543026</ArticleId><ArticleId IdType="pubmed">23204521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jover E., Matilla L., Garaikoetxea M., Fernandez-Celis A., Muntendam P., Jaisser F., et al. . (2021). Beneficial effects of mineralocorticoid receptor pathway blockade against endothelial inflammation induced by SARS-CoV-2 spike protein. Biomedicines. 9:639. doi: 10.3390/biomedicines9060639, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9060639</ArticleId><ArticleId IdType="pmc">PMC8228852</ArticleId><ArticleId IdType="pubmed">34204890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamato D., Burch M. L., Piva T. J., Rezaei H. B., Rostam M. A., Xu S., et al. . (2013). Transforming growth factor-beta signalling: role and consequences of Smad linker region phosphorylation. Cell. Signal. 25, 2017–2024. doi: 10.1016/j.cellsig.2013.06.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2013.06.001</ArticleId><ArticleId IdType="pubmed">23770288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanters E., van Rijssel J., Hensbergen P. J., Hondius D., Mul F. P., Deelder A. M., et al. . (2008). Filamin B mediates ICAM-1-driven leukocyte transendothelial migration. J. Biol. Chem. 283, 31830–31839. doi: 10.1074/jbc.M804888200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M804888200</ArticleId><ArticleId IdType="pubmed">18809679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassif-Lerner R., Zloto K., Rubin N., Asraf K., Doolman R., Paret G., et al. . (2022). mi R-155: a potential biomarker for predicting mortality in COVID-19 patients. J Pers Med. 12:324. doi: 10.3390/jpm12020324, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12020324</ArticleId><ArticleId IdType="pmc">PMC8877479</ArticleId><ArticleId IdType="pubmed">35207812</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawabata M., Imamura T., Inoue H., Hanai J., Nishihara A., Hanyu A., et al. . (1999). Intracellular signaling of the TGF-beta superfamily by Smad proteins. Ann. N. Y. Acad. Sci. 886, 73–82. doi: 10.1111/j.1749-6632.1999.tb09402.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1999.tb09402.x</ArticleId><ArticleId IdType="pubmed">10667205</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha R., Hashemi-Shahri S. M., Jebali A. (2021). The relative expression of mi R-31, mi R-29, mi R-126, and mi R-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res. 26:75. doi: 10.1186/s40001-021-00544-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00544-4</ArticleId><ArticleId IdType="pmc">PMC8276226</ArticleId><ArticleId IdType="pubmed">34256840</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney A. D., Aron S. L., Gilbert C., Kumar N., Chen P., Eddy A., et al. . (2022). Influenza virus replication in cardiomyocytes drives heart dysfunction and fibrosis. Sci. Adv. 8:eabm5371. doi: 10.1126/sciadv.abm5371, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5371</ArticleId><ArticleId IdType="pmc">PMC9094651</ArticleId><ArticleId IdType="pubmed">35544568</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A. O., Reyat J. S., Hill H., Bourne J. H., Colicchia M., Newby M. L., et al. . (2022). Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature. Cardiovasc. Res. 118, 3085–3096. doi: 10.1093/cvr/cvac097, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac097</ArticleId><ArticleId IdType="pmc">PMC9214165</ArticleId><ArticleId IdType="pubmed">35709328</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S., Harb J., Rima M., Annweiler C., Wu Y., Cao Z., et al. . (2022). The pathophysiology of long COVID throughout the renin-angiotensin system. Molecules 27:27(9). doi: 10.3390/molecules27092903</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J. S., Lee J. Y., Yang J. W., Lee K. H., Effenberger M., Szpirt W., et al. . (2021). Immunopathogenesis and treatment of cytokine storm in COVID-19. Theranostics 11, 316–329. doi: 10.7150/thno.49713, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.49713</ArticleId><ArticleId IdType="pmc">PMC7681075</ArticleId><ArticleId IdType="pubmed">33391477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Miyazaki K., Shah P., Kozai L., Kewcharoen J. (2022). Association between mineralocorticoid receptor antagonist and mortality in SARS-CoV-2 patients: a systematic review and Meta-analysis. Healthcare (Basel) 10:645. doi: 10.3390/healthcare10040645</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10040645</ArticleId><ArticleId IdType="pmc">PMC9027687</ArticleId><ArticleId IdType="pubmed">35455823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Ohta K., Hamaguchi A., Yukimura T., Miura K., Iwao H. (1995). Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25, 1252–1259. doi: 10.1161/01.HYP.25.6.1252, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.25.6.1252</ArticleId><ArticleId IdType="pubmed">7768570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolkhof P., Bärfacker L. (2017). 30 years of the mineralocorticoid receptor: Mineralocorticoid receptor antagonists: 60 years of research and development. J. Endocrinol. 234, T125–T140. doi: 10.1530/JOE-16-0600</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-16-0600</ArticleId><ArticleId IdType="pmc">PMC5488394</ArticleId><ArticleId IdType="pubmed">28634268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong P., Christia P., Frangogiannis N. G. (2014). The pathogenesis of cardiac fibrosis. Cell. Mol. Life Sci. 71, 549–574. doi: 10.1007/s00018-013-1349-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1349-6</ArticleId><ArticleId IdType="pmc">PMC3769482</ArticleId><ArticleId IdType="pubmed">23649149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotfis K., Lechowicz K., Drozdzal S., Niedzwiedzka-Rystwej P., Wojdacz T. K., Grywalska E., et al. . (2021). COVID-19-the potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection. Pharmaceuticals (Basel) 14:10071. doi: 10.3390/ph14010071, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14010071</ArticleId><ArticleId IdType="pmc">PMC7830835</ArticleId><ArticleId IdType="pubmed">33477294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kounis N. G., Gogos C., de Gregorio C., Hung M. Y., Kounis S. N., Tsounis E. P., et al. . (2024). “When”, “where”, and “how” of SARS-CoV-2 infection affects the human cardiovascular system: a narrative review. Balkan Med. J. 41, 7–22. doi: 10.4274/balkanmedj.galenos.2023.2023-10-25, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/balkanmedj.galenos.2023.2023-10-25</ArticleId><ArticleId IdType="pmc">PMC10767774</ArticleId><ArticleId IdType="pubmed">38173173</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan S., Nordqvist H., Ambikan A. T., Gupta S., Sperk M., Svensson-Akusjarvi S., et al. . (2021). Metabolic perturbation associated with COVID-19 disease severity and SARS-CoV-2 replication. Mol. Cell. Proteomics 20:100159. doi: 10.1016/j.mcpro.2021.100159, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100159</ArticleId><ArticleId IdType="pmc">PMC8490130</ArticleId><ArticleId IdType="pubmed">34619366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruglov E. A., Nathanson R. A., Nguyen T., Dranoff J. A. (2006). Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G765–G771. doi: 10.1152/ajpgi.00308.2005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00308.2005</ArticleId><ArticleId IdType="pubmed">16282363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Wang G., Zheng N., Cheng W., Ouyang K., Lin H., et al. . (2019). HIMF (hypoxia-induced Mitogenic factor)-IL (interleukin)-6 signaling mediates cardiomyocyte-fibroblast crosstalk to promote cardiac hypertrophy and fibrosis. Hypertension 73, 1058–1070. doi: 10.1161/HYPERTENSIONAHA.118.12267, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.12267</ArticleId><ArticleId IdType="pubmed">30827145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumarswamy R., Volkmann I., Jazbutyte V., Dangwal S., Park D. H., Thum T. (2012). Transforming growth factor-beta-induced endothelial-to-mesenchymal transition is partly mediated by micro RNA-21. Arterioscler. Thromb. Vasc. Biol. 32, 361–369. doi: 10.1161/ATVBAHA.111.234286, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.111.234286</ArticleId><ArticleId IdType="pubmed">22095988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan S. H., Lai C. C., Huang H. T., Chang S. P., Lu L. C., Hsueh P. R. (2020). Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Int. J. Antimicrob. Agents 56:106103. doi: 10.1016/j.ijantimicag.2020.106103, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106103</ArticleId><ArticleId IdType="pmc">PMC7377685</ArticleId><ArticleId IdType="pubmed">32712333</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Duan J. Z., He Q., Wang C. Q. (2020a). mi R155 modulates high glucoseinduced cardiac fibrosis via the Nrf 2/HO1 signaling pathway. Mol. Med. Rep. 22, 4003–4016. doi: 10.3892/mmr.2020.11495, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11495</ArticleId><ArticleId IdType="pubmed">32901848</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu R., Cui Y., Liang J., Bi Z., Li S., et al. . (2021). Protective effect of Remdesivir against pulmonary fibrosis in mice. Front. Pharmacol. 12:692346. doi: 10.3389/fphar.2021.692346, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.692346</ArticleId><ArticleId IdType="pmc">PMC8427522</ArticleId><ArticleId IdType="pubmed">34512328</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang N., Rao P., Wang L., Lu D., Sun L. (2021). Role of the micro RNA-29 family in myocardial fibrosis. J. Physiol. Biochem. 77, 365–376. doi: 10.1007/s13105-021-00814-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13105-021-00814-z</ArticleId><ArticleId IdType="pubmed">34047925</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zhou W., Yang L., You R. (2020b). Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor. Pharmacol. Res. 157:104833. doi: 10.1016/j.phrs.2020.104833, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104833</ArticleId><ArticleId IdType="pmc">PMC7194807</ArticleId><ArticleId IdType="pubmed">32302706</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S., Bao C., Yang Z., Liu S., Sun Y., Cao W., et al. . (2023). SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy. Signal Transduct. Target. Ther. 8:108. doi: 10.1038/s41392-023-01368-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01368-w</ArticleId><ArticleId IdType="pmc">PMC9998025</ArticleId><ArticleId IdType="pubmed">36894537</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Zhang N., Zhao L., Wang Q., Deng S., Shen J., et al. . (2023). Perindopril improves cardiac fibrosis through targeting the Ang II/AT1R pathway. Cell. Mol. Biol. (Noisy-le-Grand) 69, 234–238. doi: 10.14715/cmb/2023.69.9.36, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.14715/cmb/2023.69.9.36</ArticleId><ArticleId IdType="pubmed">37807306</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C. W., Chou C. H., Wu X. M., Chen Z. W., Chen Y. H., Chang Y. Y., et al. . (2020). Interleukin-6 plays a critical role in aldosterone-induced macrophage recruitment and infiltration in the myocardium. Biochim. Biophys. Acta Mol. basis Dis. 1866:165627. doi: 10.1016/j.bbadis.2019.165627, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.165627</ArticleId><ArticleId IdType="pubmed">31785407</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W., Wu J. (2021). The ACE2/Ang (1-7)/mas R axis as an emerging target for antihypertensive peptides. Crit. Rev. Food Sci. Nutr. 61, 2572–2586. doi: 10.1080/10408398.2020.1781049, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2020.1781049</ArticleId><ArticleId IdType="pubmed">32551837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lijnen P., Papparella I., Petrov V., Semplicini A., Fagard R. (2006). Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J. Hypertens. 24, 757–766. doi: 10.1097/01.hjh.0000217860.04994.54, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hjh.0000217860.04994.54</ArticleId><ArticleId IdType="pubmed">16531806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima J. A. C., Bluemke D. A. (2021). Myocardial scar in COVID-19: innocent marker versus harbinger of clinical disease. Radiology 301, E434–E435. doi: 10.1148/radiol.2021211710, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211710</ArticleId><ArticleId IdType="pmc">PMC8369879</ArticleId><ArticleId IdType="pubmed">34374597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H. Y., Wang X. F., Ng-Eaton E., Weinberg R. A., Lodish H. F. (1992). Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775–785. doi: 10.1016/0092-8674(92)90152-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90152-3</ArticleId><ArticleId IdType="pubmed">1310899</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yin Z., Xu X., Liu C., Duan X., Song Q., et al. . (2021). Crosstalk between the activated slit 2-Robo 1 pathway and TGF-beta 1 signalling promotes cardiac fibrosis. ESC Heart Fail. 8, 447–460. doi: 10.1002/ehf2.13095, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.13095</ArticleId><ArticleId IdType="pmc">PMC7835586</ArticleId><ArticleId IdType="pubmed">33236535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi A. A., Gibb A. A., Arif E., Kolmetzky D. W., Tomar D., Luongo T. S., et al. . (2019). Mitochondrial calcium exchange links metabolism with the epigenome to control cellular differentiation. Nat. Commun. 10:4509. doi: 10.1038/s41467-019-12103-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12103-x</ArticleId><ArticleId IdType="pmc">PMC6778142</ArticleId><ArticleId IdType="pubmed">31586055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes M. I., Bonjorno L. P., Giannini M. C., Amaral N. B., Menezes P. I., Dib S. M., et al. . (2021). Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 7:1455. doi: 10.1136/rmdopen-2020-001455</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2020-001455</ArticleId><ArticleId IdType="pmc">PMC7868202</ArticleId><ArticleId IdType="pubmed">33542047</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez B., Ravassa S., Moreno M. U., Jose G. S., Beaumont J., Gonzalez A., et al. . (2021). Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat. Rev. Cardiol. 18, 479–498. doi: 10.1038/s41569-020-00504-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00504-1</ArticleId><ArticleId IdType="pubmed">33568808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lother A., Moser M., Bode C., Feldman R. D., Hein L. (2015). Mineralocorticoids in the heart and vasculature: new insights for old hormones. Annu. Rev. Pharmacol. Toxicol. 55, 289–312. doi: 10.1146/annurev-pharmtox-010814-124302</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010814-124302</ArticleId><ArticleId IdType="pubmed">25251996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Tian A., Wu J., Yang C., Xing R., Jia P., et al. . (2014). Danshensu inhibits β-adrenergic receptors-mediated cardiac fibrosis by ROS/p 38 MAPK axis. Biol. Pharm. Bull. 37, 961–967. doi: 10.1248/bpb.b13-00921, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b13-00921</ArticleId><ArticleId IdType="pubmed">24882408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J. Y., Wilson J., Hou W., Fleysher R., Herold B. C., Herold K. C., et al. . (2023). Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine 90:104487. doi: 10.1016/j.ebiom.2023.104487, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104487</ArticleId><ArticleId IdType="pmc">PMC9970376</ArticleId><ArticleId IdType="pubmed">36857969</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukito A. A., Widysanto A., Lemuel T. A. Y., Prasetya I. B., Massie B., Yuniarti M., et al. . (2021). Candesartan as a tentative treatment for COVID-19: a prospective non-randomized open-label study. Int. J. Infect. Dis. 108, 159–166. doi: 10.1016/j.ijid.2021.05.019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.05.019</ArticleId><ArticleId IdType="pmc">PMC8142270</ArticleId><ArticleId IdType="pubmed">34038766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumbers E. R., Head R., Smith G. R., Delforce S. J., Jarrott B., Martin J. H., et al. . (2022). The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: key agents for treatment. Pharmacol. Res. Perspect. 10:e00917. doi: 10.1002/prp2.917, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.917</ArticleId><ArticleId IdType="pmc">PMC8929333</ArticleId><ArticleId IdType="pubmed">35106954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack M. (2018). Inflammation and fibrosis. Matrix Biol. 68-69, 106–121. doi: 10.1016/j.matbio.2017.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2017.11.010</ArticleId><ArticleId IdType="pubmed">29196207</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder J., Minko T. (2021). Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 23:14. doi: 10.1208/s12248-020-00532-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/s12248-020-00532-2</ArticleId><ArticleId IdType="pmc">PMC7784226</ArticleId><ArticleId IdType="pubmed">33400058</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleszewska M., Moonen J. R., Huijkman N., van de Sluis B., Krenning G., Harmsen M. C. (2013). IL-1beta and TGFbeta2 synergistically induce endothelial to mesenchymal transition in an NFkappaB-dependent manner. Immunobiology 218, 443–454. doi: 10.1016/j.imbio.2012.05.026, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.05.026</ArticleId><ArticleId IdType="pubmed">22739237</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi C., Paradis P., Schiffrin E. L. (2008). Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol. Sci. 29, 367–374. doi: 10.1016/j.tips.2008.05.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2008.05.003</ArticleId><ArticleId IdType="pubmed">18579222</ArticleId></ArticleIdList></Reference><Reference><Citation>Mareev V. Y., Orlova Y. A., Plisyk A. G., Pavlikova E. P., Matskeplishvili S. T., Akopyan Z. A., et al. . (2020). Results of open-label non-randomized comparative clinical Trial: "Bromhex Ine and Spironolactone for Coronаvir us infection requiring hospi Talization (BISCUIT). Kardiologiia 60, 4–15. doi: 10.18087/cardio.2020.11.n1440, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.18087/cardio.2020.11.n1440</ArticleId><ArticleId IdType="pubmed">33487145</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., et al. . (1995). Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247–250. doi: 10.1038/375247a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/375247a0</ArticleId><ArticleId IdType="pubmed">7746328</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E. D., Bassi R., Marber M. S. (2015). P 38 MAPK in cardioprotection - are we there yet? Br. J. Pharmacol. 172, 2101–2113. doi: 10.1111/bph.12901, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12901</ArticleId><ArticleId IdType="pmc">PMC4386984</ArticleId><ArticleId IdType="pubmed">25204838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P. K., Griendling K. K. (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82–C97. doi: 10.1152/ajpcell.00287.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00287.2006</ArticleId><ArticleId IdType="pubmed">16870827</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X. M., Nikolic-Paterson D. J., Lan H. Y. (2016). TGF-beta: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325–338. doi: 10.1038/nrneph.2016.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2016.48</ArticleId><ArticleId IdType="pubmed">27108839</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng G., Wu F., Yang L., Zhu H., Gu J., He M., et al. . (2009). Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan. J. Cardiovasc. Pharmacol. 54, 16–24. doi: 10.1097/FJC.0b013e3181a98b31, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181a98b31</ArticleId><ArticleId IdType="pubmed">19487956</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng Y., Yu C. H., Li W., Li T., Luo W., Huang S., et al. . (2014). Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway. Am. J. Respir. Cell Mol. Biol. 50, 723–736. doi: 10.1165/rcmb.2012-0451OC, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2012-0451OC</ArticleId><ArticleId IdType="pubmed">24168260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzaroma E., Mikkelsen R. B., Toldo S., Mauro A. G., Sharma K., Marchetti C., et al. . (2015). Role of Interleukin-1 in radiation-induced cardiomyopathy. Mol. Med. 21, 210–218. doi: 10.2119/molmed.2014.00243, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2014.00243</ArticleId><ArticleId IdType="pmc">PMC4503657</ArticleId><ArticleId IdType="pubmed">25822795</ArticleId></ArticleIdList></Reference><Reference><Citation>Miftode R. S., Petriș A. O., Onofrei Aursulesei V., Cianga C., Costache I. I., Mitu O., et al. . (2021). The novel perspectives opened by ST2 in the pandemic: a review of its role in the diagnosis and prognosis of patients with heart failure and COVID-19. Diagnostics (Basel) 11:175. doi: 10.3390/diagnostics11020175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020175</ArticleId><ArticleId IdType="pmc">PMC7911622</ArticleId><ArticleId IdType="pubmed">33530550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr A. M., Mott J. L. (2015). Overview of micro RNA biology. Semin. Liver Dis. 35, 003–011. doi: 10.1055/s-0034-1397344</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1397344</ArticleId><ArticleId IdType="pmc">PMC4797991</ArticleId><ArticleId IdType="pubmed">25632930</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A. J., Sykes R., McIntosh A., Kamdar A., Bagot C., Bayes H. K., et al. . (2022). A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat. Med. 28, 1303–1313. doi: 10.1038/s41591-022-01837-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Y., Gudey S. K., Landstrom M. (2012). Non-Smad signaling pathways. Cell Tissue Res. 347, 11–20. doi: 10.1007/s00441-011-1201-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-011-1201-y</ArticleId><ArticleId IdType="pubmed">21701805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustroph J., Hupf J., Baier M. J., Evert K., Brochhausen C., Broeker K., et al. . (2021). Cardiac fibrosis is a risk factor for severe COVID-19. Front. Immunol. 12:740260. doi: 10.3389/fimmu.2021.740260, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.740260</ArticleId><ArticleId IdType="pmc">PMC8569622</ArticleId><ArticleId IdType="pubmed">34745111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasawa K., Zimmermann R., Münkel B., Linz W., Schölkens B., Schaper J. (1995). Extracellular matrix deposition in hypertensive hearts antifibrotic effects of ramipril. Eur. Heart J. 16 Suppl C, 33–37. doi: 10.1093/eurheartj/16.suppl_C.33, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/16.suppl_C.33</ArticleId><ArticleId IdType="pubmed">7556270</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevers T., Salvador A. M., Velazquez F., Ngwenyama N., Carrillo-Salinas F. J., Aronovitz M., et al. . (2017). Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J. Exp. Med. 214, 3311–3329. doi: 10.1084/jem.20161791, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161791</ArticleId><ArticleId IdType="pmc">PMC5679176</ArticleId><ArticleId IdType="pubmed">28970239</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T. C., Oronsky A., Kesari S., Lybeck M., et al. . (2021). A review of persistent post-COVID syndrome (PPCS). Clin. Rev. Allergy Immunol. 64, 66–74. doi: 10.1007/s12016-021-08848-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G. Y., Kassiri Z., Jiang C., Liu P. P., Poutanen S. M., Penninger J. M., et al. . (2009). SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Investig. 39, 618–625. doi: 10.1111/j.1365-2362.2009.02153.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153.x</ArticleId><ArticleId IdType="pmc">PMC7163766</ArticleId><ArticleId IdType="pubmed">19453650</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotides N. G., Poledniczek M., Andreas M., Hülsmann M., Kocher A. A., Kopp C. W., et al. . (2024). Myocardial Oedema as a consequence of viral infection and persistence-a narrative review with focus on COVID-19 and post COVID sequelae. Viruses 16:121. doi: 10.3390/v16010121, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16010121</ArticleId><ArticleId IdType="pmc">PMC10818479</ArticleId><ArticleId IdType="pubmed">38257821</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizgar P., Yazdankhah N., Rzepka A. M., Chung K. Y. C., Ali I., Lai Fat Fur R., et al. . (2023). Beyond acute COVID-19: a review of long-term cardiovascular outcomes. Can. J. Cardiol. 39, 726–740. doi: 10.1016/j.cjca.2023.01.031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2023.01.031</ArticleId><ArticleId IdType="pmc">PMC9901229</ArticleId><ArticleId IdType="pubmed">36754119</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy U., Martinelli R., Vollmann E. H., Best K., Therien A. G. (2022). The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders. Biochem. Pharmacol. 195:114847. doi: 10.1016/j.bcp.2021.114847, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114847</ArticleId><ArticleId IdType="pmc">PMC8600760</ArticleId><ArticleId IdType="pubmed">34801526</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S., Rauf A., Khan H., Abu-Izneid T. (2017). Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed. Pharmacother. 94, 317–325. doi: 10.1016/j.biopha.2017.07.091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.091</ArticleId><ArticleId IdType="pubmed">28772209</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkov D. I., Liu D. X., Allers C., Didier P. J., Didier E. S., Kuroda M. J. (2019). Characterization of heart macrophages in rhesus macaques as a model to study cardiovascular disease in humans. J. Leukoc. Biol. 106, 1241–1255. doi: 10.1002/JLB.1A0119-017R, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.1A0119-017R</ArticleId><ArticleId IdType="pmc">PMC7216974</ArticleId><ArticleId IdType="pubmed">31287581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., et al. . (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone evaluation study investigators. N. Engl. J. Med. 341, 709–717. doi: 10.1056/NEJM199909023411001</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909023411001</ArticleId><ArticleId IdType="pubmed">10471456</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter K. E., Turner N. A. (2009). Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255–278. doi: 10.1016/j.pharmthera.2009.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2009.05.002</ArticleId><ArticleId IdType="pubmed">19460403</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi D., Wei M., Jiao S., Song Y., Wang X., Xie G., et al. . (2019). Hypoxia inducible factor 1alpha in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment. Cell Death Dis. 10:544. doi: 10.1038/s41419-019-1757-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1757-0</ArticleId><ArticleId IdType="pmc">PMC6639417</ArticleId><ArticleId IdType="pubmed">31320613</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z., Liu F., Blair R., Wang C., Yang H., Mudd J., et al. . (2021). Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 11, 8076–8091. doi: 10.7150/thno.61810, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.61810</ArticleId><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R. H., Tao H., Ni S. H., Shi P., Dai C., Shi K. H. (2018). micro RNA-29a inhibits cardiac fibrosis in Sprague-Dawley rats by downregulating the expression of DNMT3A. Anatol. J. Cardiol. 20, 198–205. doi: 10.14744/AnatolJCardiol.2018.98511, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/AnatolJCardiol.2018.98511</ArticleId><ArticleId IdType="pmc">PMC6249525</ArticleId><ArticleId IdType="pubmed">30297596</ArticleId></ArticleIdList></Reference><Reference><Citation>Raafs A. G., Ghossein M. A., Brandt Y., Henkens M., Kooi M. E., Vernooy K., et al. . (2022). Cardiovascular outcome 6months after severe coronavirus disease 2019 infection. J. Hypertens. 40, 1278–1287. doi: 10.1097/HJH.0000000000003110</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000003110</ArticleId><ArticleId IdType="pubmed">35221322</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani M. Y., Rappaport J., Gupta M. K. (2022). Activation of immune system may cause pathophysiological changes in the myocardium of SARS-CoV-2 infected monkey model. Cells 11:611. doi: 10.3390/cells11040611, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11040611</ArticleId><ArticleId IdType="pmc">PMC8869860</ArticleId><ArticleId IdType="pubmed">35203260</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiee M. J., Friedrich M. G. (2024). MRI of cardiac involvement in COVID-19. Br. J. Radiol. 97, 1367–1377. doi: 10.1093/bjr/tqae086, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjr/tqae086</ArticleId><ArticleId IdType="pmc">PMC11256941</ArticleId><ArticleId IdType="pubmed">38656976</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M., Kim S. J., Kim J. S., Kim S. Z., Lee Y. U., Kang H. S. (2010). Myocardial calcification and hypertension following chronic renal failure and ameliorative effects of furosemide and captopril. Cardiology 116, 194–205. doi: 10.1159/000315146, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000315146</ArticleId><ArticleId IdType="pubmed">20689276</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A., Sawano T., Sen A., Hossain A., Jahan N., Kobara H., et al. . (2021). Cardioprotective effects of a nonsteroidal mineralocorticoid receptor blocker, Esaxerenone, in dahl salt-sensitive hypertensive rats. Int. J. Mol. Sci. 22:2069. doi: 10.3390/ijms22042069, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22042069</ArticleId><ArticleId IdType="pmc">PMC7922950</ArticleId><ArticleId IdType="pubmed">33669786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao M., Wang X., Guo G., Wang L., Chen S., Yin P., et al. . (2021). Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level. Basic Res. Cardiol. 116:55. doi: 10.1007/s00395-021-00897-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-021-00897-1</ArticleId><ArticleId IdType="pubmed">34601654</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch A., Dupont A., Goutay J., Caplan M., Staessens S., Moussa M., et al. . (2020). Endotheliopathy is induced by plasma from critically ill patients and associated with organ failure in severe COVID-19. Circulation 142, 1881–1884. doi: 10.1161/CIRCULATIONAHA.120.050907, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050907</ArticleId><ArticleId IdType="pmc">PMC7643783</ArticleId><ArticleId IdType="pubmed">32970476</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezagholizadeh A., Khiali S., Sarbakhsh P., Entezari-Maleki T. (2021). Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. Eur. J. Pharmacol. 897:173926. doi: 10.1016/j.ejphar.2021.173926, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173926</ArticleId><ArticleId IdType="pmc">PMC7859696</ArticleId><ArticleId IdType="pubmed">33549577</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricard-Blum S., Baffet G., Theret N. (2018). Molecular and tissue alterations of collagens in fibrosis. Matrix Biol. 68-69, 122–149. doi: 10.1016/j.matbio.2018.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2018.02.004</ArticleId><ArticleId IdType="pubmed">29458139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg K. (2021). Remdesivir in the treatment of COVID-19. Am. J. Nurs. 121:55. doi: 10.1097/01.NAJ.0000731672.32508.dc, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.NAJ.0000731672.32508.dc</ArticleId><ArticleId IdType="pubmed">33350698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothlin R. P., Duarte M., Pelorosso F. G., Nicolosi L., Salgado M. V., Vetulli H. M., et al. . (2021). Angiotensin receptor blockers for COVID-19: pathophysiological and pharmacological considerations about ongoing and future prospective clinical trials. Front. Pharmacol. 12:603736. doi: 10.3389/fphar.2021.603736, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.603736</ArticleId><ArticleId IdType="pmc">PMC8039444</ArticleId><ArticleId IdType="pubmed">33854432</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A., Kawakami R., Kawai K., Gianatti A., Pellegrini D., Kutys R., et al. . (2021). ACE2 (angiotensin-converting enzyme 2) and TMPRSS2 (transmembrane serine protease 2) expression and localization of SARS-CoV-2 infection in the human heart. Arterioscler. Thromb. Vasc. Biol. 41, 542–544. doi: 10.1161/ATVBAHA.120.315229, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315229</ArticleId><ArticleId IdType="pubmed">33086866</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamuri S. S., Valente A. J., Siddesha J. M., Delafontaine P., Siebenlist U., Gardner J. D., et al. . (2016). TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis. Mol. Cell. Endocrinol. 429, 84–92. doi: 10.1016/j.mce.2016.03.038, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2016.03.038</ArticleId><ArticleId IdType="pmc">PMC4861697</ArticleId><ArticleId IdType="pubmed">27040306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammour Y., Spertus J. A., Austin B. A., Magalski A., Gupta S. K., Shatla I., et al. . (2021). Outpatient Management of Heart Failure during the COVID-19 pandemic after adoption of a telehealth model. JACC Heart Fail. 9, 916–924. doi: 10.1016/j.jchf.2021.07.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8494054</ArticleId><ArticleId IdType="pubmed">34857175</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D., Cano M., Ma L., Zhou D., Zhu J. H., O'Halloran J. A., et al. . (2021). Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI. Insight 6:299. doi: 10.1172/jci.insight.143299</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143299</ArticleId><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikhzadeh Hesari F., Hosseinzadeh S. S., Asl Monadi Sardroud M. A. (2021). Review of COVID-19 and male genital tract. Andrologia 53:e13914. doi: 10.1111/and.13914, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/and.13914</ArticleId><ArticleId IdType="pmc">PMC7744899</ArticleId><ArticleId IdType="pubmed">33236375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng J., Chen W., Zhu H. J. (2015). The immune suppressive function of transforming growth factor-beta (TGF-beta) in human diseases. Growth Factors 33, 92–101. doi: 10.3109/08977194.2015.1010645</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08977194.2015.1010645</ArticleId><ArticleId IdType="pubmed">25714613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppard M., Laskou F., Stapleton P. P., Hadavi S., Dasgupta B. (2017). Tocilizumab (Actemra). Hum. Vaccin. Immunother. 13, 1972–1988. doi: 10.1080/21645515.2017.1316909, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2017.1316909</ArticleId><ArticleId IdType="pmc">PMC5612212</ArticleId><ArticleId IdType="pubmed">28841363</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C., Velazquez P., Hohl T. M., Leiner I., Dustin M. L., Pamer E. G. (2010). Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J. Immunol. 184, 6266–6274. doi: 10.4049/jimmunol.0904160, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0904160</ArticleId><ArticleId IdType="pmc">PMC2921650</ArticleId><ArticleId IdType="pubmed">20435926</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A., Chapuis N., Dunsmore G., Goubet A. G., Dubuisson A., Derosa L., et al. . (2020). Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 182, 1401–1418.e18. doi: 10.1016/j.cell.2020.08.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Skelly D. A., Squiers G. T., McLellan M. A., Bolisetty M. T., Robson P., Rosenthal N. A., et al. . (2018). Single-cell transcriptional profiling reveals cellular diversity and intercommunication in the mouse heart. Cell Rep. 22, 600–610. doi: 10.1016/j.celrep.2017.12.072, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.12.072</ArticleId><ArticleId IdType="pubmed">29346760</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider P., Standley K. N., Wang J., Azhar M., Doetschman T., Conway S. J. (2009). Origin of cardiac fibroblasts and the role of periostin. Circ. Res. 105, 934–947. doi: 10.1161/CIRCRESAHA.109.201400, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.201400</ArticleId><ArticleId IdType="pmc">PMC2786053</ArticleId><ArticleId IdType="pubmed">19893021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolski M., Kalużna-Oleksy M., Tycińska A., Jankowska E. A. (2023). Telemedicine in heart failure in the COVID-19 and post-pandemic era: what have we learned? Biomedicines 11:2222. doi: 10.3390/biomedicines11082222, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082222</ArticleId><ArticleId IdType="pmc">PMC10452788</ArticleId><ArticleId IdType="pubmed">37626719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Ruan Y., Yan M., Xu K., Yang Y., Shen T., et al. . (2021). Ferulic acid alleviates oxidative stress-induced cardiomyocyte injury by the regulation of mi R-499-5p/p 21 signal Cascade. Evid. Based Complement. Alternat. Med. 2021, 1–15. doi: 10.1155/2021/1921457</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/1921457</ArticleId><ArticleId IdType="pmc">PMC8670946</ArticleId><ArticleId IdType="pubmed">34917156</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiderski J., Gadanec L. K., Apostolopoulos V., Moore G. J., Kelaidonis K., Matsoukas J. M., et al. . (2023). Role of angiotensin II in cardiovascular diseases: introducing Bisartans as a novel therapy for coronavirus 2019. Biomol. Ther. 13:787. doi: 10.3390/biom13050787, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13050787</ArticleId><ArticleId IdType="pmc">PMC10216788</ArticleId><ArticleId IdType="pubmed">37238657</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczerbinski L., Okruszko M. A., Szablowski M., Solomacha S., Sowa P., Kiszkiel L., et al. . (2023). Long-term effects of COVID-19 on the endocrine system - a pilot case-control study. Front. Endocrinol. 14:1192174. doi: 10.3389/fendo.2023.1192174, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1192174</ArticleId><ArticleId IdType="pmc">PMC10544976</ArticleId><ArticleId IdType="pubmed">37790604</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki Y., Lee S. M., Dongqing Z., Kitada M., Kanasaki K., Koya D. (2020). Endothelial autophagy deficiency induces IL6- dependent endothelial mesenchymal transition and organ fibrosis. Autophagy 16, 1905–1914. doi: 10.1080/15548627.2020.1713641, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1713641</ArticleId><ArticleId IdType="pmc">PMC8386622</ArticleId><ArticleId IdType="pubmed">31965901</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Gao Y., Li Z., Miao Y., Huang Z., Liu X., et al. . (2020). The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med. 10:e200. doi: 10.1002/ctm2.200, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten Dijke P., Hill C. S. (2004). New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29, 265–273. doi: 10.1016/j.tibs.2004.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2004.03.008</ArticleId><ArticleId IdType="pubmed">15130563</ArticleId></ArticleIdList></Reference><Reference><Citation>Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., et al. . (2008). Micro RNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980–984. doi: 10.1038/nature07511</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07511</ArticleId><ArticleId IdType="pubmed">19043405</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian X., Sun C., Wang X., Ma K., Chang Y., Guo Z., et al. . (2020). ANO1 regulates cardiac fibrosis via ATI-mediated MAPK pathway. Cell Calcium 92:102306. doi: 10.1016/j.ceca.2020.102306, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2020.102306</ArticleId><ArticleId IdType="pubmed">33075549</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmermans P. B., Chiu A. T., Herblin W. F., Wong P. C., Smith R. D. (1992). Angiotensin II receptor subtypes. Am. J. Hypertens. 5, 406–410. doi: 10.1093/ajh/5.6.406</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/5.6.406</ArticleId><ArticleId IdType="pubmed">1524767</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler D. L., Pruzansky A. J., Naderi S., Ambrosy A. P., Slade J. J. (2022). Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician. Curr. Atheroscler. Rep. 24, 563–570. doi: 10.1007/s11883-022-01032-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers J. G., Kamal F. A., Robbins J., Yutzey K. E., Blaxall B. C. (2016). Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021–1040. doi: 10.1161/CIRCRESAHA.115.306565, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306565</ArticleId><ArticleId IdType="pmc">PMC4800485</ArticleId><ArticleId IdType="pubmed">26987915</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C., Van Linthout S., Jager S., Arndt R., Trippel T., Muller I., et al. . (2020). Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis. ESC Heart Fail. 7, 2838–2852. doi: 10.1002/ehf2.12887, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12887</ArticleId><ArticleId IdType="pmc">PMC7405199</ArticleId><ArticleId IdType="pubmed">32662949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou C. L., Peters W., Si Y., Slaymaker S., Aslanian A. M., Weisberg S. P., et al. . (2007). Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902–909. doi: 10.1172/JCI29919, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29919</ArticleId><ArticleId IdType="pmc">PMC1810572</ArticleId><ArticleId IdType="pubmed">17364026</ArticleId></ArticleIdList></Reference><Reference><Citation>Usui E., Nagaoka E., Ikeda H., Ohmori M., Tao S., Yonetsu T., et al. . (2023). Fulminant myocarditis with COVID-19 infection having normal C-reactive protein and serial magnetic resonance follow-up. ESC Heart Fail. 10, 1426–1430. doi: 10.1002/ehf2.14228, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14228</ArticleId><ArticleId IdType="pmc">PMC10053182</ArticleId><ArticleId IdType="pubmed">36401586</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallee A., Lecarpentier Y. (2019). TGF-beta in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci. 9:98. doi: 10.1186/s13578-019-0362-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-019-0362-3</ArticleId><ArticleId IdType="pmc">PMC6902440</ArticleId><ArticleId IdType="pubmed">31827764</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Putten S., Shafieyan Y., Hinz B. (2016). Mechanical control of cardiac myofibroblasts. J. Mol. Cell. Cardiol. 93, 133–142. doi: 10.1016/j.yjmcc.2015.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.11.025</ArticleId><ArticleId IdType="pubmed">26620422</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rooij E., Sutherland L. B., Thatcher J. E., DiMaio J. M., Naseem R. H., Marshall W. S., et al. . (2008). Dysregulation of micro RNAs after myocardial infarction reveals a role of mi R-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A. 105, 13027–13032. doi: 10.1073/pnas.0805038105, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0805038105</ArticleId><ArticleId IdType="pmc">PMC2529064</ArticleId><ArticleId IdType="pubmed">18723672</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tin H., Rethi L., Higa S., Kao Y. H., Chen Y. J. (2024). Spike protein of SARS-CoV-2 activates cardiac Fibrogenesis through NLRP3 Inflammasomes and NF-kappa B signaling. Cells 13:1331. doi: 10.3390/cells13161331</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells13161331</ArticleId><ArticleId IdType="pmc">PMC11353017</ArticleId><ArticleId IdType="pubmed">39195221</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A. J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A. S., et al. . (2020). Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417–1418. doi: 10.1016/S0140-6736(20)30937-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianello E., Dozio E., Tacchini L., Frati L., Corsi Romanelli M. M. (2019). ST2/IL-33 signaling in cardiac fibrosis. Int. J. Biochem. Cell Biol. 116:105619. doi: 10.1016/j.biocel.2019.105619</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2019.105619</ArticleId><ArticleId IdType="pubmed">31561019</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar A. V., Garcia R., Merino D., Llano M., Cobo M., Montalvo C., et al. . (2013). Myocardial and circulating levels of micro RNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int. J. Cardiol. 167, 2875–2881. doi: 10.1016/j.ijcard.2012.07.021, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.07.021</ArticleId><ArticleId IdType="pubmed">22882958</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello A., Ferrara F. (2020). Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19. Life Sci. 262:118510. doi: 10.1016/j.lfs.2020.118510, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118510</ArticleId><ArticleId IdType="pmc">PMC7521881</ArticleId><ArticleId IdType="pubmed">32991879</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A. C., Park Y. J., Tortorici M. A., Wall A., McGuire A. T., Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6. doi: 10.1016/j.cell.2020.02.058, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Fan K., Zhao Y., Xie M. L. (2021). Apigenin attenuates TGF-beta 1-stimulated cardiac fibroblast differentiation and extracellular matrix production by targeting mi R-155-5p/c-ski/Smad pathway. J. Ethnopharmacol. 265:113195. doi: 10.1016/j.jep.2020.113195</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2020.113195</ArticleId><ArticleId IdType="pubmed">32800930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. D., Xu S., Johns D. G., Du Y., Quinn M. T., Cayatte A. J., et al. . (2001). Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88, 947–953. doi: 10.1161/hh0901.089987, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hh0901.089987</ArticleId><ArticleId IdType="pubmed">11349005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Xu Y., Wang M., Ye J., Liu J., Jiang H., et al. . (2018). TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice. EBioMedicine 36, 54–62. doi: 10.1016/j.ebiom.2018.08.022, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.08.022</ArticleId><ArticleId IdType="pmc">PMC6197736</ArticleId><ArticleId IdType="pubmed">30297144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Ye D., Wang M., Zhao M., Li D., Ye J., et al. . (2020). Clinical features of COVID-19 patients with different outcomes in Wuhan: a retrospective observational study. Biomed. Res. Int. 2020, 1–10. doi: 10.1155/2020/2138387</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2138387</ArticleId><ArticleId IdType="pmc">PMC7537706</ArticleId><ArticleId IdType="pubmed">33029494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhao X., Wei W., Fan W., Gao K., He S., et al. . (2021). Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients. BMC Infect. Dis. 21:114. doi: 10.1186/s12879-021-05821-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05821-5</ArticleId><ArticleId IdType="pmc">PMC7829637</ArticleId><ArticleId IdType="pubmed">33494713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D., Dietrich O., Mari T., von Stillfried S., Ibarra I. L., Mittermaier M., et al. . (2021). SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 184, 6243–6261.e27. doi: 10.1016/j.cell.2021.11.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson B. N., Feldmann F., Schwarz B., Meade-White K., Porter D. P., Schulz J., et al. . (2020). Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature 585, 273–276. doi: 10.1038/s41586-020-2423-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2423-5</ArticleId><ArticleId IdType="pmc">PMC7486271</ArticleId><ArticleId IdType="pubmed">32516797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C. K. S., Falkenham A., Myers T., Légaré J. F. (2018). Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis. J. Renin-Angiotensin-Aldosterone Syst. 19:59358. doi: 10.1177/1470320318759358, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320318759358</ArticleId><ArticleId IdType="pmc">PMC5888824</ArticleId><ArticleId IdType="pubmed">29575960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Hu R., Zhang C., Ren W., Yu A., Zhou X. (2020). Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit. Care 24:290. doi: 10.1186/s13054-020-03015-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03015-0</ArticleId><ArticleId IdType="pmc">PMC7273814</ArticleId><ArticleId IdType="pubmed">32503680</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Q., Tang S., Li Y. (2022). The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Ann. Palliat. Med. 11, 1253–1263. doi: 10.21037/apm-21-972</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/apm-21-972</ArticleId><ArticleId IdType="pubmed">34775774</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., et al. . (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-Centre longitudinal study. Clin. Microbiol. Infect. 27, 89–95. doi: 10.1016/j.cmi.2020.09.023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J. L., Gan X. X., Ni J., Shao D. C., Shen Y., Miao N. J., et al. . (2018). SND p 102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad 3 pathway. Acta Pharmacol. Sin. 39, 1513–1521. doi: 10.1038/aps.2017.184, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.184</ArticleId><ArticleId IdType="pmc">PMC6289350</ArticleId><ArticleId IdType="pubmed">30150789</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Tan B., Huang D., Yuan M., Li T., Wu M., et al. . (2021). Remdesivir inhibits Tubulointerstitial fibrosis in obstructed kidneys. Front. Pharmacol. 12:626510. doi: 10.3389/fphar.2021.626510, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.626510</ArticleId><ArticleId IdType="pmc">PMC8284048</ArticleId><ArticleId IdType="pubmed">34276356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Nilsson-Payant B. E., Han Y., Jaffre F., Zhu J., Wang P., et al. . (2021). Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2. Stem Cell Rep. 16, 2274–2288. doi: 10.1016/j.stemcr.2021.07.012, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.07.012</ArticleId><ArticleId IdType="pmc">PMC8289700</ArticleId><ArticleId IdType="pubmed">34403650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S. Y., Koh D. H., Choi M., Ryoo S., Huh K., Yeom J. S., et al. . (2022). Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis. Emerg. Microbes Infect. 11, 1154–1165. doi: 10.1080/22221751.2022.2059405, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2059405</ArticleId><ArticleId IdType="pmc">PMC9037226</ArticleId><ArticleId IdType="pubmed">35343397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Zheng Y., Sun H. X., Yu D. J. (2012). Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS/P38MAPK/TGF-β1 signaling pathway. Molecules 17, 2738–2751. doi: 10.3390/molecules17032738, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules17032738</ArticleId><ArticleId IdType="pmc">PMC6268937</ArticleId><ArticleId IdType="pubmed">22395404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisberg E. M., Tarnavski O., Zeisberg M., Dorfman A. L., McMullen J. R., Gustafsson E., et al. . (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952–961. doi: 10.1038/nm1613</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1613</ArticleId><ArticleId IdType="pubmed">17660828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z., Hong X. Y., Li Y., Chen W., Ye G., Li Y., et al. . (2020). Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19. Biomark. Med 14, 1619–1629. doi: 10.2217/bmm-2020-0410</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2020-0410</ArticleId><ArticleId IdType="pubmed">33336592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. E. (2017). Non-Smad signaling pathways of the TGF-beta family. Cold Spring Harb. Perspect. Biol. 9:a022129. doi: 10.1101/cshperspect.a022129</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a022129</ArticleId><ArticleId IdType="pmc">PMC5287080</ArticleId><ArticleId IdType="pubmed">27864313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W. J., Chen S. J., Zhou S. C., Wu S. Z., Wang H. (2021). Inflammasomes and fibrosis. Front. Immunol. 12:643149. doi: 10.3389/fimmu.2021.643149, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.643149</ArticleId><ArticleId IdType="pmc">PMC8226128</ArticleId><ArticleId IdType="pubmed">34177893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Zhang X., Guo X., Li W., Zhang T., Chai D., et al. . (2024). Remdesivir alleviates skin fibrosis by suppressing TGF-beta 1 signaling pathway. PLoS One 19:e0305927. doi: 10.1371/journal.pone.0305927</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0305927</ArticleId><ArticleId IdType="pmc">PMC11257276</ArticleId><ArticleId IdType="pubmed">39024326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Abdurehim A., Yuan Y., Yang T., Li C., Zhang Y., et al. . (2023). Natural products: a potential new Hope to defeat post-acute sequelae of COVID-19. Curr. Top. Med. Chem. 23, 2436–2451. doi: 10.2174/1568026623666230829164156, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026623666230829164156</ArticleId><ArticleId IdType="pubmed">37644742</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y. Y., Ma Y. T., Zhang J. Y., Xie X. (2020). COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259–260. doi: 10.1038/s41569-020-0360-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Xi D., Liu J., Zhao J., Chen S., Guo Z. (2016). Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats. Drug Des. Devel. Ther. 10, 1581–1588. doi: 10.2147/DDDT.S100095</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S100095</ArticleId><ArticleId IdType="pmc">PMC4862356</ArticleId><ArticleId IdType="pubmed">27217725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X. L., Wang X. G., Hu B., Zhang L., Zhang W., et al. . (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. doi: 10.1038/s41586-020-2012-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J. N., Chen R., Fu Y. H., Lin Q. X., Huang S., Guo L. L., et al. . (2013). Smad 3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLoS One 8:e75557. doi: 10.1371/journal.pone.0075557, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075557</ArticleId><ArticleId IdType="pmc">PMC3783413</ArticleId><ArticleId IdType="pubmed">24086569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J. Y., Wang G., Huang X., Lee H., Lee J. G., Yang P., et al. . (2022). SARS-CoV-2 Nsp 6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis. Commun. Biol. 5:1039. doi: 10.1038/s42003-022-03986-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03986-6</ArticleId><ArticleId IdType="pmc">PMC9523645</ArticleId><ArticleId IdType="pubmed">36180527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipeto D., Palmeira J. D. F., Arganaraz G. A., Arganaraz E. R. (2020). ACE2/ADAM17/TMPRSS2 interplay may be the Main risk factor for COVID-19. Front. Immunol. 11:576745. doi: 10.3389/fimmu.2020.576745</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575774</ArticleId><ArticleId IdType="pubmed">33117379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>